Exalenz Bioscience Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
IL0011048688
Medical Equipment, Supplies & Distribution
Sales 2018 | 13.14M 3.54M 1.31B 4.84M | Sales 2019 | 14.04M 3.78M 1.4B 5.18M | Capitalization | 77.67M 20.92M 7.77B 28.62M |
---|---|---|---|---|---|
Net income 2018 | -5M -1.35M -500M -1.84M | Net income 2019 | -1M -269K -100M -368K | EV / Sales 2018 | 15.2 x |
Net Debt 2018 | 2.93M 788K 293M 1.08M | Net Debt 2019 | 3.09M 833K 309M 1.14M | EV / Sales 2019 | 5.75 x |
P/E ratio 2018 |
-34.6
x | P/E ratio 2019 |
-40
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 24.36% |
Managers | Title | Age | Since |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 10-09-30 |
Moshe Dori
DFI | Director of Finance/CFO | - | 19-01-28 |
Eitan Blank
COO | Chief Operating Officer | 54 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 16-07-03 |
Moshe Arkin
BRD | Director/Board Member | 69 | 05-12-31 |
Hanna Lerman
BRD | Director/Board Member | 51 | 15-04-15 |
1st Jan change | Capi. | |
---|---|---|
-3.72% | 184B | |
-0.59% | 107B | |
-2.69% | 69.44B | |
+3.46% | 50.37B | |
+8.32% | 44.82B | |
+3.40% | 41.53B | |
+3.07% | 26.84B | |
+3.69% | 26.73B | |
+15.23% | 25.71B |